ARx, LLC’s Post

#DigitalPathology is transforming the pace of drug discovery. Read our Clinical Insights paper and learn more! https://lnkd.in/eCvqPgey

In #drugdevelopment, there is a critical need to innovate beyond mere computational enhancements and adopt a holistic approach that ensures the entire drug development process is geared towards achieving successful clinical outcomes. Learn how AtlasGEN Novel Drug Designer accomplishes this in our latest white paper: https://hubs.li/Q02DMjK_0

🧬 Scientifically Bold Monday - Edition 10 🧬 We believe in making decisions based on sound science and published research. With our tools, you can rely on validated data to guide your drug discovery process—no guesswork, just informed choices. 🔬 Ready to make data-driven decisions in drug design? Learn more: https://lnkd.in/eqGCh49N #BioSolveIT #DrugDiscovery #MedicinalChemistry

At Divergent, we believe that clinical research is more than just a process - it's a journey of discovery driven by a deep commitment to patient well-being and a relentless pursuit of innovation. So, as a leading clinical research organization (CRO), we approach each challenge with a unique blend of disciplined expertise and intuitive understanding. Listening and understanding form the foundation of our approach. We take the time to deeply engage with our clients, partners, and the patients we serve, making sure that we have a comprehensive grasp of their needs, concerns, and aspirations. This understanding allows us to navigate the complexities of clinical trials with unparalleled precision, anticipating and addressing obstacles before they can impede progress. To learn more about us, visit divergentcro.com  #pharma #research #biotech #medical #monitoring #qualityassurance #quality #drug 

Improving The Clinical Trial Ecosystem: A Call To Stakeholder Alignment https://lnkd.in/edrwxW_U - By Rob Freishtat, MD, MPH In theory, all of the stakeholders in drug development — investors, scientists, regulators, and patients — share the common goal of creating safe and effective drugs.

In this feature with Drug Development & Delivery, Andy Lewis, Chief Scientific Officer, speaks on our #TranslationalPharmaceutics® platform and its benefits to accelerating and controlling the full #drugdevelopment value chain, including implementing adaptive clinical trial designs and transforming the traditional model. Read the full article here: https://bit.ly/4bqABaj

“Using adaptive clin­ical trial designs in early development can help rapidly advance a fit-for-phase for­mulation to a POC-ready format, optimize performance of a drug product in re­sponse to emerging clinical data, and gain valuable data to inform the next stage of development.” Read the full article to understand the benefits #TranslationalPharmaceutics could have on your clinical development projects. #QuotientSciences

Traditional methods of patient finding are no longer meeting the unique needs of biopharma companies. Why? They're disconnected. Finding patients is a multi-faceted problem, but typical service providers are only addressing one small part of the larger whole, forcing their clients to have to integrate multiple solutions. In the end, this can lead to unnecessary complications, higher expenses for the manufacturers, delayed diagnoses, and sub-optimal outcomes for patients. Learn how Ambit is going beyond traditional patient finding: https://hubs.li/Q02LzxSD0 #patientfinding #raredisease #patientfindingchallenges #biopharma #biotech

Complex challenges call for a nimble approach. And, because every clinical trial looks different, every LabConnect solution looks different. Need to hit an exceedingly tight timeline? Or fast-track custom collection kits? Learn how our nimble approach can help accelerate your drug development milestones. Download the case study today => https://lnkd.in/g9fr2D7K #LabConnect #CaseStudy #ClinicalTrial #Nimble

#LabConnect #CaseStudy #ClinicalTrial #Nimble Complex challenges call for a nimble approach. And, because every clinical trial looks different, every LabConnect solution looks different. Need to hit an exceedingly tight timeline? Or fast-track custom collection kits? Learn how our nimble approach can help accelerate your drug development milestones. Download the case study today 👉 https://lnkd.in/g9fr2D7K